About this trial
The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with long-term weight control and health. Most research has looked at how the body responds to the medication and whether patients take it as prescribed, but not much is known about what patients actually experience, what they think they need, or how they could use additional support. Understanding patients' views can help create better lasting solutions. Note that this study does not provide free GLP-1 medication.
Eligibility criteria
Qualifiers
Adults aged 18 and older
Recently has been prescribed GLP-1 therapy for the treatment of obesity or T2DM but have not yet initiated the medication
Has regular access to a smartphone and internet to complete short surveys and food recalls online
Willing to sign informed consent.
Disqualifiers
Already began the GLP-1 medication
Have medical concerns making participation unsafe
Trial design
Treatments tested in this trial
- GLP-1 Therapy
Treatment groups
Locations
2Sponsors and collaborators
University of South Carolina
Lead sponsor
Prisma Health-Upstate
Collaborator